Brain metabolism predicts survival in advanced non–small cell lung cancer patients

Brain metabolism predicts survival in advanced non–small cell lung cancer patients. Low brain metabolism as measured by ¹⁸F-FDG PET/CT is associated with higher mortality in patients with advanced non-small cell lung cancer (NSCLC), according to new research published in The Journal of Nuclear Medicine.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Low brain metabolism as measured by ¹⁸F-FDG PET/CT is associated with higher mortality in patients with advanced non-small cell lung cancer (NSCLC), according to new research published in The Journal of Nuclear Medicine. Incorporating brain ¹⁸F-FDG uptake alongside clinical, tumor and biological data improved prediction of overall survival, providing physicians with valuable insight to help identify patients most likely to benefit from early supportive care.

• Ponto de atenção: brain.
• Ponto de atenção: metabolism.
• Ponto de atenção: predicts.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.